LS POLARIS INNOVATION FUND
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research.
Similar Organizations
Emerging Innovations Fund
Emerging Innovations Fund is an initiative that aims to accelerate the commercialization of early stage technologies in the Purdue.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-07 | Satellite Bio | LS Polaris Innovation Fund investment in Series A - Satellite Bio | 82.47 M USD |
| 2021-07-09 | Muna Therapeutics | LS Polaris Innovation Fund investment in Series A - Muna Therapeutics | 73 M USD |
| 2020-11-17 | Satellite Bio | LS Polaris Innovation Fund investment in Seed Round - Satellite Bio | 19 M USD |
| 2020-07-15 | Glympse Bio | LS Polaris Innovation Fund investment in Series B - Glympse Bio | 46.7 M USD |
| 2020-05-13 | QurAlis | LS Polaris Innovation Fund investment in Series A - QurAlis | 42 M USD |
| 2018-10-09 | Glympse Bio | LS Polaris Innovation Fund investment in Series A - Glympse Bio | 22 M USD |
More informations about "LS Polaris Innovation Fund"
Polaris Innovation Fund - Polaris Partners
Polaris Innovation Fund fosters company creation and growth through an active investment model. Our team brings decades of experience in healthcare investing and entrepreneurship …See details»
LS Polaris Innovation Fund: Performance - PitchBook
Dec 31, 2018 · LS Polaris Innovation Fund is a 2017 vintage venture capital fund managed by Polaris Partners. The fund is located in Boston, Massachusetts. The fund targets investments …See details»
Polaris Innovation Fund - LinkedIn
By partnering with passionate entrepreneurs with transformational science, the Polaris Innovation Fund fosters company creation and growth through an active investment model. Our team …See details»
Polaris Partners - Crunchbase Investor Profile
Polaris Partners invests in early-stage companies, focusing on healthcare, biotechnology, and medical industries, with a geographical emphasis on the United States, particularly in Massachusetts and New York.See details»
Amy Schulman | Fractyl Health
Amy Schulman is a healthcare investor and managing partner of the LS Polaris Innovation Fund. She is a highly respected leader in the biotech and pharmaceutical industries. Ms. Schulman …See details»
LS Polaris Innovation Fund - Company Profile & Staff Directory
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research. By partnering with passionate entrepreneurs with …See details»
LS Polaris Innovation Fund - LinkedIn
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research. By partnering with passionate entrepreneurs with...See details»
Polaris Innovation Fund – 65LAB
Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early-stage academic research. By partnering with passionate entrepreneurs with transformational …See details»
LS Polaris Innovation Fund - Unicorn Nest
Among the most successful fund investment fields, there are Life Science, Biotechnology. Among the various public portfolio startups of the fund, we may underline Glympse Bio. The standard …See details»
Polaris Innovation Fund II: Performance | PitchBook
Polaris Innovation Fund II is an early-stage venture capital fund managed by Polaris Partners. The fund is located in Boston, Massachusetts. The fund targets therapeutic devices sectors.See details»
LS Polaris Innovation Fund - SignalHire
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research. By partnering with passionate entrepreneurs with …See details»
How Does Polaris Partners Invest in the Life Sciences? - Excedr
Jul 26, 2022 · Polaris’ main funds provide capital to life sciences, healthcare, and biopharmaceutical companies. Its top-funded companies include those in which co …See details»
Polaris Partners - Investments, Portfolio & Company Exits
Polaris Partners 's most notable exits include CAMP4 Therapeutics, Kronos Bio, and Alnylam Pharmaceuticals. Polaris Partners has acquired 4 organizations. Their most recent acquisition …See details»
QurAlis strengthens its Board along with raising $42m Series A ...
May 13, 2020 · – USA, MA – QurAlis Corporation, a biotech company focused on developing precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, …See details»
QurAlis raises $42 Million Series A Financing to Develop New …
May 13, 2020 · The financing was led by LS Polaris Innovation Fund, lead seed investor Mission BioCapital, INKEF Capital and the Dementia Discovery Fund, and co-led by Droia Ventures.See details»
LS Polaris Innovation Fund LP | AUM 13F
Public filings of LS Polaris Innovation Fund LP raised by Polaris Growth Management LLC. Direct links to the EDGAR source material.See details»
LS POLARIS INNOVATION FUND MANAGEMENT, L.L.C. | Form …
Jun 13, 2018 · Firm Details for LS POLARIS INNOVATION FUND MANAGEMENT, L.L.C., Location: Massachusetts, AUM = None, Last Form ADV Filed : 13-June-2018, Officers: …See details»
Experts in Residence (XIRs) - Harvard Office of Technology …
Our network of Experts in Residence (XIRs) offers a powerful resource for Harvard innovators working to commercialize a technology, navigating the launch of a startup, or seeking …See details»
QurAlis raises $42 Million Series A Financing to ... - Business Wire
May 13, 2020 · The financing was led by LS Polaris Innovation Fund, lead seed investor Mission BioCapital, INKEF Capital and the Dementia Discovery Fund, and co-led by Droia Ventures.See details»
LS Polaris Innovation Fund - BioCentury Company Profiles - BCIQ
May 13, 2020 · LS Polaris Innovation Fund - BioCentury Company Profiles for the biopharma industrySee details»